Liabilities, Current of Sagimet Biosciences Inc. from 31 Dec 2022 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
Summary
Sagimet Biosciences Inc. quarterly Liabilities, Current in USD history and change rate from 31 Dec 2022 to 30 Sep 2025.
  • Sagimet Biosciences Inc. Liabilities, Current for the quarter ending 30 Sep 2025 was $9,146,000.
Source SEC data
View on sec.gov
Liabilities, Current, Quarterly (USD)
Liabilities, Current, YoY Quarterly Change (%)

Sagimet Biosciences Inc. Quarterly Liabilities, Current (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $9,146,000 30 Sep 2025 10-Q 13 Nov 2025 2025 Q3
Q2 2025 $7,247,000 30 Jun 2025 10-Q 13 Aug 2025 2025 Q2
Q4 2024 $4,454,000 -$1,200,000 -21% 31 Dec 2024 10-Q 13 Nov 2025 2025 Q3
Q4 2023 $5,654,000 +$375,000 +7.1% 31 Dec 2023 10-K 12 Mar 2025 2024 FY
Q3 2023 $5,049,000 30 Sep 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 $5,287,000 30 Jun 2023 10-Q 21 Aug 2023 2023 Q2
Q4 2022 $5,279,000 31 Dec 2022 10-K 25 Mar 2024 2023 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.